Stroke is the loss of brain function due to a disturbance in the blood supply to the brain resulting from either ischemia or hemorrhage. Previous studies have evaluated the clinical importance of nutritional interventions such as vitamin B supplementation in the management of acute strokes. However, it is still inconclusive whether or not vitamin B supplementation will benefit patients with acute strokes. Therefore, a meta-analysis was performed to assess the efficacy of vitamin B supplementation in the treatment of stroke patients. Medline, Embase, Scopus, and Cochrane Library databases were searched (from 1960 to June 2015) and forest plots were generated to illustrate the treatment effects. A systemic review of the electronic databases yielded 12 eligible studies consisting of 7474 patients. Forest plots from the meta-analyses of the included studies illustrated that vitamin B supplementation significantly lowered the plasma concentration of total homocysteine (SMD = -0.82; 95% CI: -0.77; Z = -29.06, p < 0.0001) and resulted in significant reduction in stroke recurrence (OR = 0.86%; 95% CI: 0.76, 0.97; Z = -2.41; p = 0.016) as well as a combined incidence of vascular events, including recurrent strokes, myocardial infarctions and vascular deaths (OR = 0.87%; 95% CI: 0.79, 0.96; Z= -2.73; p = 0.0063). Additionally, the nearly-symmetrical funnel plot (Egger's test, t = −1.705, p = 0.1224) indicated the absence of publication bias regarding the meta-analysis that examined the effect of vitamin B supplementation on the plasma levels of homocysteine in acute stroke patients. These findings suggested that vitamin B supplementation presents a potential addition to the armamentarium for the management of acute stroke patients.
introduction
Although considerable progress has been made in the management of stroke patients, stroke is still one of the leading causes of mortality and morbidity worldwide [1] . It can be classified into two major categories, ischemic or hemorrhagic stroke, which result either from obstruction of the blood supply or from rupture of a blood vessel, respectively Substantial epidemiological studies have demonstrated that elevated plasma level of total homocysteine is a common risk factor for both primary and recurrent strokes [3, 4] . As compared to placebo intervention, vitamin B (folic acid, vitamin B 12 , and vitamin B 6 ) supplementation has been documented to effectively lower the plasma levels of total homocysteine and serves to reduce the risk of strokes in high-risk and healthy subjects [5] . Furthermore, multiple randomized, controlled trials have also documented the clinical efficacy of B-vitamin supplementation in decreasing the plasma concentrations of homocysteine [6] [7] [8] and in improving the clinical outcomes in patients with recent strokes [9, 10] . However, it is still inconclusive whether vitamin B supplementation is beneficial in treating stroke patients and improving the rehabilitation of those patients. In addition, most of the randomized controlled trials were mainly conducted on small populations, which may lack statistical power and thus lead to inconsistency among further studies. 
Inclusion criteria
The articles that were included into this metaanalysis matched the following five criteria:
(1) patients were clinically diagnosed with acute strokes, (2) studies that determined the effect of vitamin B supplementation on the plasma levels of homocysteine, (3) studies that 
Statistical analysis
All statistical analyses were carried out using moderate heterogeneity; 50-90%: substantial heterogeneity; 75-100% considerable heterogeneity) [12] .
To evaluate the publication bias concerning this meta-analysis, a funnel plot was generated in which asymmetry of the scatter plot would indicate publication bias [13] . Meanwhile, an
Egger's test [14] was further performed to assess the asymmetry of the funnel plot.
results

Characteristics of included studies
Initially, 1464 relevant studies were identified using the search strategies as described Notably, as summarized in B-vitamin supplementation reduces the levels of plasma homocysteine Substantial evidence suggests that elevated plasma levels of total homocysteine are an independent risk factor for stroke [3, 22] and contribute to the inflammation and oxidative stress-induced neuronal cell death in stroke patients [23] . Therefore, a meta-analysis patients with acute ischemic stroke [28] .
Intravenous tPA given within 6 hours of strokes, considerably improves the functional outcomes and increases the odds of survival and independency [28, 29] . However, there are still challenges that need to be addressed regarding the use of tPA for this purpose. As mentioned above, tPA must be administered to stroke patients within several hours after the onset of the ischemic stroke to dissolve the blood clot [29] . Additionally, treatment with intravenous tPA is associated with increased rates of intracranial hemorrhage, which may be fatal [29] . Thus, the relatively short therapeutic References
